Annual Accounts Receivable
$27.68 M
+$16.34 M+144.08%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual accounts receivable is $27.68 million, with the most recent change of +$16.34 million (+144.08%) on December 31, 2023.
- During the last 3 years, RVNC annual accounts receivable has risen by +$25.85 million (+1413.18%).
- RVNC annual accounts receivable is now at all-time high.
Performance
RVNC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$48.26 M
+$12.18 M+33.74%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly accounts receivable is $48.26 million, with the most recent change of +$12.18 million (+33.74%) on September 30, 2024.
- Over the past year, RVNC quarterly accounts receivable has increased by +$22.85 million (+89.91%).
- RVNC quarterly accounts receivable is now at all-time high.
Performance
RVNC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RVNC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +144.1% | +89.9% |
| 3 y3 years | +1413.2% | +2810.9% |
| 5 y5 years | +2.5% | +865.3% |
RVNC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +726.6% | at high | +1341.5% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Revance Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $48.26 M(+33.7%) |
| Jun 2024 | - | $36.09 M(+20.7%) |
| Mar 2024 | - | $29.89 M(+8.0%) |
| Dec 2023 | $27.68 M(+144.1%) | $27.68 M(+8.9%) |
| Sep 2023 | - | $25.41 M(+49.1%) |
| Jun 2023 | - | $17.04 M(+10.9%) |
| Mar 2023 | - | $15.37 M(+35.6%) |
| Dec 2022 | $11.34 M(+238.7%) | $11.34 M(-3.3%) |
| Sep 2022 | - | $11.73 M(+109.9%) |
| Jun 2022 | - | $5.59 M(+25.0%) |
| Mar 2022 | - | $4.47 M(+33.5%) |
| Dec 2021 | $3.35 M(+83.1%) | $3.35 M(+101.9%) |
| Sep 2021 | - | $1.66 M(+158.7%) |
| Jun 2021 | - | $641.00 K(-87.6%) |
| Mar 2021 | - | $5.19 M(+183.5%) |
| Dec 2020 | $1.83 M | $1.83 M(-29.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $2.58 M(+5175.5%) |
| Jun 2020 | - | $49.00 K(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $5.00 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $27.00 M(>+9900.0%) | $27.00 M(>+9900.0%) |
| Dec 2017 | $48.00 K(-62.5%) | $48.00 K(-62.5%) |
| Dec 2016 | $128.00 K(+70.7%) | $128.00 K(+70.7%) |
| Dec 2015 | $75.00 K(-75.0%) | $75.00 K(-75.0%) |
| Dec 2014 | $300.00 K(+33.3%) | $300.00 K(-78.9%) |
| Sep 2014 | - | $1.42 M(+655.9%) |
| Jun 2014 | - | $188.00 K(-89.5%) |
| Mar 2014 | - | $1.79 M(+693.8%) |
| Dec 2013 | $225.00 K(+200.0%) | $225.00 K(+200.0%) |
| Dec 2012 | $75.00 K | $75.00 K |
FAQ
- What is Revance Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Revance Therapeutics?
- What is Revance Therapeutics annual accounts receivable year-on-year change?
- What is Revance Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Revance Therapeutics?
- What is Revance Therapeutics quarterly accounts receivable year-on-year change?
What is Revance Therapeutics annual accounts receivable?
The current annual accounts receivable of RVNC is $27.68 M
What is the all time high annual accounts receivable for Revance Therapeutics?
Revance Therapeutics all-time high annual accounts receivable is $27.68 M
What is Revance Therapeutics annual accounts receivable year-on-year change?
Over the past year, RVNC annual accounts receivable has changed by +$16.34 M (+144.08%)
What is Revance Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of RVNC is $48.26 M
What is the all time high quarterly accounts receivable for Revance Therapeutics?
Revance Therapeutics all-time high quarterly accounts receivable is $48.26 M
What is Revance Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, RVNC quarterly accounts receivable has changed by +$22.85 M (+89.91%)